145 related articles for article (PubMed ID: 8570730)
41. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
42. Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL).
Haedersdal M; Sakamoto FH; Farinelli WA; Doukas AG; Tam J; Anderson RR
Lasers Surg Med; 2014 Aug; 46(6):462-9. PubMed ID: 24842112
[TBL] [Abstract][Full Text] [Related]
43. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
Fijan S; Hönigsmann H; Ortel B
Br J Dermatol; 1995 Aug; 133(2):282-8. PubMed ID: 7547399
[TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy in dermatology.
Fritsch C; Goerz G; Ruzicka T
Arch Dermatol; 1998 Feb; 134(2):207-14. PubMed ID: 9487213
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid.
Xu S; Wang X; Xu W; Xia Y; Zhang C
Chin Med J (Engl); 2002 Aug; 115(8):1141-5. PubMed ID: 12215278
[TBL] [Abstract][Full Text] [Related]
46. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid.
Fritsch C; Abels C; Goetz AE; Stahl W; Bolsen K; Ruzicka T; Goerz G; Sies H
Biol Chem; 1997 Jan; 378(1):51-7. PubMed ID: 9049065
[TBL] [Abstract][Full Text] [Related]
47. [Photodynamic diagnosis and therapy of neoplasms of the facial skin after topical administration of 5-aminolevulinic acid].
Lang S; Baumgartner R; Struck R; Leunig A; Gutmann R; Feyh J
Laryngorhinootologie; 1995 Feb; 74(2):85-9. PubMed ID: 7710611
[TBL] [Abstract][Full Text] [Related]
48. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
[TBL] [Abstract][Full Text] [Related]
49. Tissue distribution and penetration of 5-ALA induced fluorescence in an amelanotic melanoma after topical application.
Pahernik S; Langer S; Botzlar A; Dellian M; Goetz AE
Anticancer Res; 2001; 21(1A):59-63. PubMed ID: 11299790
[TBL] [Abstract][Full Text] [Related]
50. The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid.
Bugaj A; Juzeniene A; Juzenas P; Iani V; Ma LW; Moan J
J Photochem Photobiol B; 2006 May; 83(2):94-7. PubMed ID: 16442808
[TBL] [Abstract][Full Text] [Related]
51. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
van der Veen N; de Bruijn HS; Berg RJ; Star WM
Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
[TBL] [Abstract][Full Text] [Related]
52. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
53. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues.
Heyerdahl H; Wang I; Liu DL; Berg R; Andersson-Engels S; Peng Q; Moan J; Svanberg S; Svanberg K
Cancer Lett; 1997 Jan; 112(2):225-31. PubMed ID: 9066732
[TBL] [Abstract][Full Text] [Related]
55. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.
Rodriguez L; Vallecorsa P; Battah S; Di Venosa G; Calvo G; Mamone L; Sáenz D; Gonzalez MC; Batlle A; MacRobert AJ; Casas A
Photochem Photobiol Sci; 2015 Sep; 14(9):1617-27. PubMed ID: 26066768
[TBL] [Abstract][Full Text] [Related]
56. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
57. Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin.
Sakamoto FH; Tannous Z; Doukas AG; Farinelli WA; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2009 Feb; 41(2):154-60. PubMed ID: 19226576
[TBL] [Abstract][Full Text] [Related]
58. The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors.
Orenstein A; Kostenich G; Malik Z
Cancer Lett; 1997 Dec; 120(2):229-34. PubMed ID: 9461042
[TBL] [Abstract][Full Text] [Related]
59. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
60. Fluorescence diagnosis of face-located basal cell carcinomas: a new dermatological procedure which may help the surgeon.
Vereecken P; Da Costa CM; Steels E; De Lathouwer O; Heenen M; De Mey A
Acta Chir Belg; 2007; 107(2):205-7. PubMed ID: 17515272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
